{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-102855","form_type":"8-K","ticker":"ISPC","cik":"0001558569","company_name":"iSpecimen Inc.","filed_at":"2024-09-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.504874+00:00","generated_at":"2026-05-31T01:47:59.662139+00:00","sec_items":["1.01","2.03","5.02","9.01"],"event_type":"debt","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"iSpecimen closes $1M note at 18% interest; lender secures three board seats","bullets":["Issued $1M senior note with 18% annual interest, maturing in 12 months; net proceeds $960,000 after $40,000 placement fee.","Three directors (Gullans, Mock, Graham) resigned; lender-designated directors Paolone, Dhaliwal, Field appointed effective Sept 25, 2024.","Additional $1M revolving credit line available upon filing of a registration statement for a $5M+ public offering.","New chairperson Katie Field; Paolone and Dhaliwal also join board committees."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-102855","json":"https://secwatch.observer/filing/0001104659-24-102855.json","markdown":"https://secwatch.observer/filing/0001104659-24-102855.md","text":"https://secwatch.observer/filing/0001104659-24-102855.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1558569/000110465924102855/0001104659-24-102855-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1558569/000110465924102855/tm2424693d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T01:47:59.662139+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"08db291a48","claim":"Steven Gullans resigned as Director at iSpecimen Inc..","evidence_excerpt":"The Company received letters of resignation from each of Steven Gullans and Theresa Mock, each as a member of the Board","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465924102855/0001104659-24-102855-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"0f1477208c","claim":"Katherine (Katie) Field was appointed as Chairperson at iSpecimen Inc..","evidence_excerpt":"effective upon Closing on September 25, 2024, Richard Paolone, Avtar Dhaliwal and Katherine (Katie) Field were each appointed to serve on the Board as a Class I director, a Class II director and a Class III director of the Company, respectively, with Ms. Field appointed as the chairperson of the Board","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465924102855/0001104659-24-102855-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chairperson"}],"fact_type":"executive_change"},{"claim_id":"1e6515b108","claim":"Elizabeth A. Graham resigned as Director at iSpecimen Inc..","evidence_excerpt":"Elizabeth A. Graham, as a member and the chairperson of the Board, effective upon Closing","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465924102855/0001104659-24-102855-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"23f82df2e7","claim":"Theresa Mock resigned as Director at iSpecimen Inc..","evidence_excerpt":"The Company received letters of resignation from each of Steven Gullans and Theresa Mock, each as a member of the Board","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465924102855/0001104659-24-102855-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"811905ca10","claim":"Avtar Dhaliwal was appointed as Director at iSpecimen Inc..","evidence_excerpt":"effective upon Closing on September 25, 2024, Richard Paolone, Avtar Dhaliwal and Katherine (Katie) Field were each appointed to serve on the Board","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465924102855/0001104659-24-102855-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"a8c717c044","claim":"Richard Paolone was appointed as Director at iSpecimen Inc..","evidence_excerpt":"effective upon Closing on September 25, 2024, Richard Paolone, Avtar Dhaliwal and Katherine (Katie) Field were each appointed to serve on the Board","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1558569/000110465924102855/0001104659-24-102855-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}